These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 16614884

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M, Zamboli A, De Vita F, Galizia G.
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [Abstract] [Full Text] [Related]

  • 3. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G, Lieto E, Ferraraccio F, Orditura M, De Vita F, Castellano P, Imperatore V, Romano C, Ciardiello F, Agostini B, Pignatelli C.
    Clin Cancer Res; 2004 May 15; 10(10):3490-9. PubMed ID: 15161706
    [Abstract] [Full Text] [Related]

  • 4. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM, Carvalho AL, Pinto CA, Martins EP, Filho JG, Soares FA, Kowalski LP.
    Arch Otolaryngol Head Neck Surg; 2008 Jul 15; 134(7):743-9. PubMed ID: 18645125
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 15; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ, Brosens RP, Delis-van Diemen PM, Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann HB, Meijer S, Meijer GA.
    Ann Surg Oncol; 2012 Jul 15; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [Abstract] [Full Text] [Related]

  • 9. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1455-61. PubMed ID: 17445998
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J, Hong A, Dobbins TA, Jones D, Lee CS, Loo C, Al-Ghamdi M, Harnett GB, Clark J, O'Brien CJ, Rose B.
    Ann Surg Oncol; 2009 Oct 01; 16(10):2908-17. PubMed ID: 19603236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR, Wu HG, Park CI, Jun YK, Kim CW.
    Head Neck; 2008 Jul 01; 30(7):852-7. PubMed ID: 18302259
    [Abstract] [Full Text] [Related]

  • 14. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y, Inoue Y, Saigusa S, Okugawa Y, Yokoe T, Tanaka K, Miki C, Kusunoki M.
    Clin Oncol (R Coll Radiol); 2010 May 01; 22(4):272-80. PubMed ID: 20117921
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.
    Li S, Kim JS, Kim JM, Cho MJ, Yoon WH, Song KS, Yeo SG, Kim JS.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):705-12. PubMed ID: 16690221
    [Abstract] [Full Text] [Related]

  • 16. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
    Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA.
    Clin Cancer Res; 2005 Aug 15; 11(16):5856-62. PubMed ID: 16115926
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
    Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S.
    J Clin Oncol; 2004 Dec 01; 22(23):4772-8. PubMed ID: 15570078
    [Abstract] [Full Text] [Related]

  • 18. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM, Gatalica Z, Lilleberg S, Haynatzki G, Loggie BW.
    Ann Surg Oncol; 2009 Jan 01; 16(1):152-8. PubMed ID: 18998063
    [Abstract] [Full Text] [Related]

  • 19. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
    Di Lorenzo G, Tortora G, D'Armiento FP, De Rosa G, Staibano S, Autorino R, D'Armiento M, De Laurentiis M, De Placido S, Catalano G, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2002 Nov 01; 8(11):3438-44. PubMed ID: 12429632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.